Ciglitazone and rosiglitazone effectively suppressed DCs maturation, retarded vascular injury, attenuated cell apoptosis and atherosclerosis formation through activating peroxisome proliferator-activated receptor γ (PPARγ) [13,16,18]. This evidence concerns the gene PPARG and atherosclerosis.